We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

184 hedge funds and large institutions have $761M invested in Acorda Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 79 increasing their positions, 41 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 41

24% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 21

3% more funds holding

Funds holding: 179 → 184 (+5)

8% less capital invested

Capital invested by funds: $826M → $761M (-$65M)

52% less call options, than puts

Call options by funds: $2.4M | Put options by funds: $5.05M

Holders
184
Holders Change
+5
Holders Change %
+2.79%
% of All Funds
3.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
79
Reduced
41
Closed
21
Calls
$2.4M
Puts
$5.05M
Net Calls
-$2.65M
Net Calls Change
-$26M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$27.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$11.5M
3
State Street
State Street
Massachusetts
+$9.6M
4
Prudential Financial
Prudential Financial
New Jersey
+$6.06M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$5.08M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$17.3M
2
Invesco
Invesco
Georgia
-$17.1M
3
SCM
Scopia Capital Management
New York
-$15.5M
4
Millennium Management
Millennium Management
New York
-$11M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIP
126
Convergence Investment Partners
Florida
$219K -$16.2K -9 -6%
Tudor Investment Corp
127
Tudor Investment Corp
Connecticut
$206K -$809K -449 -78%
OPERF
128
Oregon Public Employees Retirement Fund
Oregon
$203K +$3.6K +2 +2%
LSERS
129
Louisiana State Employees Retirement System
Louisiana
$197K -$1.8K -1 -0.8%
MLICM
130
Metropolitan Life Insurance Company (MetLife)
New York
$193K – – –
Canada Pension Plan Investment Board
131
Canada Pension Plan Investment Board
Ontario, Canada
$190K +$214K +119 New
MWNA
132
Marshall Wace North America
New York
$183K +$207K +115 New
COPPSERS
133
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$180K – – –
SOADOR
134
State of Alaska Department of Revenue
Alaska
$177K +$1.8K +1 +0.9%
FQ
135
First Quadrant
California
$177K +$73.9K +41 +59%
MSA
136
Mason Street Advisors
Wisconsin
$169K +$7.21K +4 +4%
SLF
137
Sun Life Financial
Ontario, Canada
$168K – – –
BMC
138
Benin Management Corp
Connecticut
$156K – – –
MERSOM
139
Municipal Employees' Retirement System of Michigan
Michigan
$153K +$3.6K +2 +2%
NIT
140
NumerixS Investment Technologies
British Columbia, Canada
$152K +$95.5K +53 +123%
Public Employees Retirement Association of Colorado
141
Public Employees Retirement Association of Colorado
Colorado
$146K – – –
GHCM
142
Glen Harbor Capital Management
California
$141K – – –
XK
143
Xact Kapitalforvaltning
Sweden
$140K – – –
BNP Paribas Financial Markets
144
BNP Paribas Financial Markets
France
$136K +$137K +76 +844%
AG
145
Aperio Group
California
$135K -$14.4K -8 -9%
TRSOTSOK
146
Teachers Retirement System of the State of Kentucky
Kentucky
$134K – – –
PIA
147
Piedmont Investment Advisors
North Carolina
$134K +$151K +84 New
Simplex Trading
148
Simplex Trading
Illinois
$129K +$146K +81 New
MCIM
149
Meadow Creek Investment Management
Georgia
$116K – – –
SAM
150
Shell Asset Management
Netherlands
$94K – – –
4 5
6
7 8

ACOR Hedge Fund Activity: Q1 2019 in Review

184 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q1 2019, worth a combined $761M — down 7.9% from $826M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 21 closed out — a net gain of 5 holders — while 79 added to existing stakes and 41 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $27.4M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $17.3M sold.

  • 184 institutional investors held Acorda Therapeutics (ACOR) as of Q1 2019, up from 179 in Q4 2018.
  • Funds reported $761M of Acorda Therapeutics stock for Q1 2019, down 7.9% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q1 2019 and 21 closed out, a net change of +5 holders.
  • The largest Acorda Therapeutics buyer in Q1 2019 was Renaissance Technologies, an estimated $27.4M added.
  • The largest Acorda Therapeutics seller in Q1 2019 was PFM Health Sciences, an estimated $17.3M sold.

Based on aggregated 13F filings for Q1 2019.